ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
68.016,19
0,43%
Brent Oil
81,295
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Opko Health Inc (OPK)

  7. Opko Health Inc (OPK) Notícias

OPK

Opko Health (OPK)

Opko Health Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OPK
DataHoraFonteTítuloCódigoCompanhia
31/05/202411:48GlobeNewswire Inc.OPKO Health to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OPKOpko Health Inc
07/05/202417:29Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPKOpko Health Inc
07/05/202417:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPKOpko Health Inc
07/05/202417:05GlobeNewswire Inc.OPKO Health Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
03/05/202409:00GlobeNewswire Inc.OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:OPKOpko Health Inc
28/03/202409:00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics BusinessNASDAQ:OPKOpko Health Inc
20/03/202409:00GlobeNewswire Inc.Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel SyndromeNASDAQ:OPKOpko Health Inc
07/03/202418:02Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:OPKOpko Health Inc
05/03/202410:52GlobeNewswire Inc.AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIVNASDAQ:OPKOpko Health Inc
01/03/202418:05Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:OPKOpko Health Inc
28/02/202411:31PR Newswire (US)NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1stNASDAQ:OPKOpko Health Inc
27/02/202418:05GlobeNewswire Inc.OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
22/02/202418:05GlobeNewswire Inc.OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024NASDAQ:OPKOpko Health Inc
16/02/202418:53Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPKOpko Health Inc
05/02/202410:09PR Newswire (US)NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in ChinaNASDAQ:OPKOpko Health Inc
29/01/202417:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPKOpko Health Inc
24/01/202418:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:OPKOpko Health Inc
09/01/202418:05GlobeNewswire Inc.OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional NotesNASDAQ:OPKOpko Health Inc
08/01/202410:00GlobeNewswire Inc.OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:OPKOpko Health Inc
05/01/202401:31GlobeNewswire Inc.OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029NASDAQ:OPKOpko Health Inc
03/01/202419:05GlobeNewswire Inc.OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029NASDAQ:OPKOpko Health Inc
28/11/202309:00PR Newswire (US)BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and TestingNASDAQ:OPKOpko Health Inc
07/11/202308:45PR Newswire (US)BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™NASDAQ:OPKOpko Health Inc
06/11/202318:05GlobeNewswire Inc.OPKO Health Reports Third Quarter 2023 Business Highlights and Financial ResultsNASDAQ:OPKOpko Health Inc
02/11/202311:00GlobeNewswire Inc.New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023NASDAQ:OPKOpko Health Inc
31/10/202317:08Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OPKOpko Health Inc
31/10/202309:00GlobeNewswire Inc.OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023NASDAQ:OPKOpko Health Inc
25/10/202317:25GlobeNewswire Inc.OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023NASDAQ:OPKOpko Health Inc
28/09/202318:10Dow Jones NewsModeX Therapeutics Awarded Contract to Address Public Health Threat From Viral DiseasesNASDAQ:OPKOpko Health Inc
28/09/202317:08GlobeNewswire Inc.ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease ThreatsNASDAQ:OPKOpko Health Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:OPK

Seu Histórico Recente

BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados